11 Recruiting Studies Using Entrectinib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Entrectinib
Genetic Testing in Guiding Treatment for Patients With Brain Metastases
π Anchorage Associates in Radiation Medicine β Anchorage, Alaska
CDK Gene Mutation
View Study & Checklist βA Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)
π Northwest Cancer Specialists, P.C. β Tigard, Oregon
Non-Small Cell Lung Cancer
View Study & Checklist βBasket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
π Dignity Health St Joseph's Hospital and Medical Center β Phoenix, Arizona
Breast Cancer
View Study & Checklist βA Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
π UC Davis β Sacramento, California
Non-Small Cell Lung Cancer
View Study & Checklist βTumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
π Western Regional Medical Center at Cancer Treatment Centers of America β Goodyear, Arizona
Solid Tumors
View Study & Checklist βA Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases
π Oncocentro ServiΓ§os MΓ©dicos e Hospitalares Ltda β Fortaleza, CearΓ‘
Carcinoma, Non-Small-Cell Lung
View Study & Checklist βEntrectinib in Combination With ASTX727 for the Treatment of Relapsed/Refractory TP53 Mutated Acute Myeloid Leukemia
π OHSU Knight Cancer Institute β Portland, Oregon
Acute Myeloid Leukemia
View Study & Checklist βStudy Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
π University of California San Diego β La Jolla, California
Solid Tumors
View Study & Checklist βA Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
π City of Hope Comprehensive Cancer Center β Duarte, California
Non-small Cell Lung Cancer
View Study & Checklist βEntrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
π St. Jude Children's Research Hospital β Memphis, Tennessee
High Grade Glioma
View Study & Checklist βA Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
π GHdC Site Les Viviers β Charleroi,
Cancer
View Study & Checklist β